Kovack Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,434
Closed -$232K 680
2021
Q2
$232K Buy
+1,434
New +$232K 0.03% 591